| Execution period | Vesting not earlier than 2 years; Exercise period max 1 year from vesting |
|---|
NSE filing, NSE: KAYA. Summary written from the filing by ALFA Finder's alert engine.
Kaya Ltd: key numbers
- Share price
- ₹308.35
- Market cap
- ₹468.3 Cr
- Revenue (annual)
- ₹222.5 Cr
- Net profit (annual)
- ₹-96.13 Cr
- P/E (TTM)
- -4.8×Sector 34.1×
- Promoter holding
- 51.43%+0.00% QoQ
- FII holding
- 0.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kaya Ltd
All →Kaya Preferential Issue
Kaya Limited received in-principle approval from stock exchanges for its preferential issue of 18,24,150 equity shares, aggregating to Rs. 49.99 Crore.
- Value
- ₹49.99 Cr
Kaya Other Announcement
Kaya Limited has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
Kaya Employee Stock Options
Kaya Ltd received in-principle exchange approval to list 4,00,000 ESOP shares under its 2021 plan. The shares arise from employee stock option exercise.
Kaya Capital Structure Change
Kaya Limited clarified shareholding patterns and lock-in details regarding its previously announced preferential issue of 18,24,150 equity shares valued at approximately ₹50 Crore.
- Value
- ₹50.00 Cr
Kaya Results Correction
Kaya clarified to NSE that consolidated results for Q1 FY27 were not applicable after its sole subsidiary dissolved in April 2026. Standalone results were filed on time.
Kaya Annual General Meeting
Kaya Limited held an EGM on September 05, 2026, to consider preferential share issuance, management appointments, and amendments to its employee stock option plan.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date